GLP-1s Raise Eating-Disorder Fears

LouisvilleIn a small study, 10% of eating-disorder patients misused GLP-1s.

Anorexia and bulimia incidence rose 71% from 1990 to 2023, a JAMA Psychiatry study found.

Cynthia Bulik fears faster weight loss in people with anorexia, who may reach advanced illness harder to reverse.

The JAMA Psychiatry study did not examine why cases rose, and the 10% figure comes from a small study.

Bulik helped write guidelines this month urging doctors to screen for eating disorders before prescribing GLP-1s.

Sources: MIT Technology Review